YNIOS PHARMA develops innovative treatments aimed at preventing and minimizing ischemia/reperfusion injuries, critical factors in many Intensive Care scenarios, including septic shock, acute ischemic stroke, acute myocardial infarction, organ transplantation, and surgical procedures where blood flow is temporarily interrupted and restored.